These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17194546

  • 41. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
    Kranz G, Sycha T, Voller B, Gleiss A, Schnider P, Auff E.
    Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
    [Abstract] [Full Text] [Related]

  • 42. Sympathetic modulation of acute cutaneous flare induced by intradermal injection of capsaicin in anesthetized rats.
    Lin Q, Zou X, Fang L, Willis WD.
    J Neurophysiol; 2003 Feb; 89(2):853-61. PubMed ID: 12574463
    [Abstract] [Full Text] [Related]

  • 43. [First results of clinical studies on botulinum toxin A in migraine and headache].
    Tiesler U.
    Nervenarzt; 2008 Jun; 79 Suppl 1():44-6. PubMed ID: 18927967
    [Abstract] [Full Text] [Related]

  • 44. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury.
    Wasner G, Lee BB, Engel S, McLachlan E.
    Brain; 2008 Sep; 131(Pt 9):2387-400. PubMed ID: 18669485
    [Abstract] [Full Text] [Related]

  • 45. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC, Chancellor MB.
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [Abstract] [Full Text] [Related]

  • 46. Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model.
    Van der Schueren BJ, Rogiers A, Vanmolkot FH, Van Hecken A, Depré M, Kane SA, De Lepeleire I, Sinclair SR, de Hoon JN.
    J Pharmacol Exp Ther; 2008 Apr; 325(1):248-55. PubMed ID: 18216286
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Influence of topical capsaicin on facial sensitivity in response to experimental pain.
    Lee YS, Kho HS, Kim YK, Chung SC.
    J Oral Rehabil; 2007 Jan; 34(1):9-14. PubMed ID: 17207073
    [Abstract] [Full Text] [Related]

  • 49. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
    Nagarajan V, Al-Shubaili A, Ayad YM, Alexander J, Al-Ramezi K.
    Med Princ Pract; 2007 Jan; 16(3):181-6. PubMed ID: 17409751
    [Abstract] [Full Text] [Related]

  • 50. Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use.
    Parsa AA, Lye KD, Parsa FD.
    Aesthetic Plast Surg; 2007 Jan; 31(2):188-91; discussion 192-3. PubMed ID: 17122996
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: a randomized, double-blind, placebo-controlled trial.
    Kashkouli MB, Salimi S, Bakhtiari P, Parvaresh MM, Sanjari MS, Naseripour M.
    Ann Plast Surg; 2008 Apr; 60(4):353-6. PubMed ID: 18362558
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Homotopic and heterotopic variation in skin blood flow and temperature following experimental muscle pain in humans.
    Lei J, You HJ, Andersen OK, Graven-Nielsen T, Arendt-Nielsen L.
    Brain Res; 2008 Sep 26; 1232():85-93. PubMed ID: 18680731
    [Abstract] [Full Text] [Related]

  • 55. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients.
    Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D, German-Austrian Retrospective Study Group.
    Dermatol Surg; 2007 Jan 26; 33(1 Spec No.):S18-25. PubMed ID: 17241409
    [Abstract] [Full Text] [Related]

  • 56. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C, Yariv S, Adler R, Badarny S, Eisenberg E.
    Clin J Pain; 2008 Jan 26; 24(1):5-10. PubMed ID: 18180629
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.
    Singh JA, Mahowald ML, Noorbaloochi S.
    Transl Res; 2009 May 26; 153(5):205-16. PubMed ID: 19375681
    [Abstract] [Full Text] [Related]

  • 59. Botulinum toxin in the treatment of OAB, BPH, and IC.
    Smith CP.
    Toxicon; 2009 Oct 26; 54(5):639-46. PubMed ID: 19268490
    [Abstract] [Full Text] [Related]

  • 60. Evoked human oesophageal hyperalgesia: a potential tool for analgesic evaluation?
    Olesen AE, Staahl C, Brock C, Arendt-Nielsen L, Drewes AM.
    Basic Clin Pharmacol Toxicol; 2009 Aug 26; 105(2):126-36. PubMed ID: 19422357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.